EFFICACY AND SAFETY OF LENALIDOMIDE IN COMBINATION WITH DEXAMETASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA

被引:0
|
作者
Canovas, A. [1 ]
Alonso, J. J. [2 ]
Barreiro, B. [2 ]
机构
[1] UPV, Cruces Univ Hosp, Baracaldo, Vizcaya, Spain
[2] Osakidetza, Baracaldo, Vizacaya, Spain
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1621
引用
收藏
页码:625 / 625
页数:1
相关论文
共 50 条
  • [31] A REAL-WORLD EFFICACY AND SAFETY ANALYSIS OF CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE (KRD) COMBINATION IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
    Caratozzolo, I.
    Tacchetti, P.
    Zambello, R.
    Pantani, L.
    Antonioli, E.
    Mancuso, K.
    Buda, G.
    Rocchi, S.
    Canepa, L.
    Rizzello, I.
    Gamberi, B.
    Barila, G.
    Testoni, N.
    Marzocchi, G.
    Zamagni, E.
    Cavo, M.
    [J]. HAEMATOLOGICA, 2019, 104 : 66 - 66
  • [32] Pembrolizumab in combination with lenalidomide and low-dose dexamethasone for relapsed/refractory multiple myeloma (RRMM): Final efficacy and safety analysis.
    Mateos, Maria-Victoria
    Orlowskit, Robert Z.
    Siegel, David Samuel DiCapua
    Reece, Donna Ellen
    Moreau, Philippe
    Ocio, Enrique M.
    Shah, Jatin J.
    Rodriguez-Oterot, Paula
    Munshi, Nikhil C.
    Avigan, David
    Ge, Joy Yang
    Marinello, Patricia Maria
    Miguel, Jesus San
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma
    Chen, Christine
    Reece, Donna E.
    Siegel, David
    Niesvizky, Ruben
    Boccia, Ralph V.
    Stadtmauer, Edward A.
    Abonour, Rafat
    Richardson, Paul
    Matous, Jeffrey
    Kumar, Shaji
    Bahlis, Nizar J.
    Alsina, Melissa
    Vescio, Robert
    Coutre, Steven E.
    Pietronigro, Dennis
    Knight, Robert D.
    Zeldis, Jerome B.
    Rajkumar, Vincent
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (02) : 164 - 170
  • [35] Efficacy of lenalidomide plus dexamethasone in relapsed/refractory multiple myeloma: A systematic review
    Tandy, Fenia
    Hadisurya, Audrey
    Suciningtias, Marlyn
    Chrystelle, Celine
    Kurniawan, Andree
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S489 - S489
  • [36] EFFICACY BY CYTOGENETIC RISK STATUS FOR DARATUMUMAB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE OR BORTEZOMIB AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    San-Miguel, J.
    Weisel, K.
    Cook, G.
    Leiba, M.
    Suzuki, K.
    Kumar, S.
    Cavo, M.
    Avet-Loiseau, H.
    Quach, H.
    Hungria, V.
    Lentzsch, S.
    Hajek, R.
    Sonneveld, P.
    Wu, K.
    Qin, X.
    Chiu, C.
    Soong, D.
    Qi, M.
    Schecter, J.
    Dimopoulos, M. A.
    [J]. HAEMATOLOGICA, 2017, 102 : 1 - 2
  • [37] An Open-Label Phase I Study of the Safety and Efficacy of RAD001 in Combination with Lenalidomide in the Treatment of Patients with Relapsed and Relapsed/Refractory Multiple Myeloma
    Raje, Noopur
    Richardson, Paul
    Hari, Parameswaran N.
    Mahindra, Anuj
    Kaster, Sarah
    Connolly, Christine
    Rivera, Linda
    Chetri, Gaurav
    Dean, Sarah
    Jacobs, Paulette
    Saad, Ayman
    Laubach, Jacob
    Ghobrial, Irene M.
    Schlossman, Robert L.
    Adams, Jennifer
    Makrides, Wendy
    Weller, Edie
    Munshi, Nikhil
    Anderson, Kenneth C.
    [J]. BLOOD, 2009, 114 (22) : 1483 - 1483
  • [38] Efficacy, safety, and cost of pomalidomide in relapsed and refractory multiple myeloma
    Gueneau, Pauline
    Chretien, Marie-Lorraine
    Cransac-Miet, Amelie
    Aho, Ludwig Serge
    Lafon, Ingrid
    Favennec, Camille
    Guy, Julien
    Caillot, Denis
    Boulin, Mathieu
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (05) : 518 - 525
  • [39] Efficacy and safety of daratumumab in the treatment of relapsed/refractory multiple myeloma
    Chen, Pingping
    Ma, Jiexian
    Qian, Wensi
    Wu, Min
    Shen, Lin
    Xie, Yanhui
    [J]. MINERVA PEDIATRICS, 2024, 76 (01): : 121 - 123
  • [40] LENALIDOMIDE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Okada, K.
    Okamoto, Y.
    Tsukamoto, T.
    Sugiura, H.
    Matsui, H.
    Ueda, T.
    Jo, T.
    Onishi, T.
    Kunitomi, A.
    Ueda, Y.
    [J]. ANNALS OF ONCOLOGY, 2013, 24